Dis-Chem Pharmacies Limited

JSE:DCP Voorraadrapport

Marktkapitalisatie: R32.5b

Dis-Chem Pharmacies Beheer

Beheer criteriumcontroles 4/4

De CEO Dis-Chem Pharmacies is Rui Morais, benoemd in Jul2023, heeft een ambtstermijn van 1.33 jaar. De totale jaarlijkse vergoeding van { bedraagt ZAR 16.70M, bestaande uit 74.8% salaris en 25.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.99% van de aandelen van het bedrijf, ter waarde ZAR 321.45M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.3 jaar en 3.8 jaar.

Belangrijke informatie

Rui Morais

Algemeen directeur

R16.7m

Totale compensatie

Percentage CEO-salaris74.8%
Dienstverband CEO1.3yrs
Eigendom CEO1.0%
Management gemiddelde ambtstermijn2.3yrs
Gemiddelde ambtstermijn bestuur3.8yrs

Recente managementupdates

Recent updates

These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well

Aug 21
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well

Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Jun 06
Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Apr 17
Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Feb 26
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dec 30
Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Sep 07
If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Aug 16
Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Jul 31
Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

May 09
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Mar 29
There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Jan 14
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Nov 04
Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 04
Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Sep 01
We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Jul 04
Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Jun 21
A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Jun 08
Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

May 25
The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Feb 23
Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Feb 08
Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dec 13
I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Nov 09
Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Analyse CEO-vergoeding

Hoe is Rui Morais's beloning veranderd ten opzichte van Dis-Chem Pharmacies's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Aug 31 2024n/an/a

R1b

May 31 2024n/an/a

R1b

Feb 29 2024R17mR12m

R984m

Nov 30 2023n/an/a

R942m

Aug 31 2023n/an/a

R899m

May 31 2023n/an/a

R949m

Feb 28 2023R18mR12m

R1b

Nov 30 2022n/an/a

R1b

Aug 31 2022n/an/a

R1b

May 31 2022n/an/a

R946m

Feb 28 2022R14mR11m

R853m

Nov 30 2021n/an/a

R815m

Aug 31 2021n/an/a

R776m

May 31 2021n/an/a

R722m

Feb 28 2021R6mR6m

R669m

Nov 30 2020n/an/a

R655m

Aug 31 2020n/an/a

R641m

May 31 2020n/an/a

R620m

Feb 29 2020R6mR6m

R598m

Nov 30 2019n/an/a

R573m

Aug 31 2019n/an/a

R549m

May 31 2019n/an/a

R634m

Feb 28 2019R5mR5m

R719m

Nov 30 2018n/an/a

R718m

Aug 31 2018n/an/a

R718m

May 31 2018n/an/a

R701m

Feb 28 2018R7mR5m

R684m

Compensatie versus markt: De totale vergoeding ($USD 964.89K ) Rui } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de ZA markt ($USD 1.41M ).

Compensatie versus inkomsten: De vergoeding van Rui is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Rui Morais (40 yo)

1.3yrs

Tenure

R16,702,000

Compensatie

Mr. Rui Manuel Morais, CA(SA) has been the Chief Executive Officer at Dis-Chem Pharmacies Limited since July 01, 2023 and its Executive Director since August 13, 2012. He served as Chief Financial Officer...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Rui Morais
CEO & Executive Director1.3yrsR16.70m0.99%
ZAR 321.4m
J. Pope
CFO & Executive Director1.3yrsR5.19mgeen gegevens
Ivan Saltzman
Executive Director1.4yrsR18.45mgeen gegevens
Lynette Saltzman
Managing Director19.5yrsR14.97mgeen gegevens
Saul Saltzman
Executive Director2.3yrsR7.56m0.79%
ZAR 255.0m
Stanley Richard Goetsch
Executive Director2.3yrsR7.58m4.65%
ZAR 1.5b
Christopher Williams
Prescribed Officerno dataR7.81mgeen gegevens
Craig Fairweather
Commercial Directorno dataR15.38m0.0045%
ZAR 1.5m
C. Swanepoel
Prescribed Officerno dataR4.61m0.0012%
ZAR 379.8k
T. Ponter
Prescribed Officerno dataR5.11mgeen gegevens
Caryn Barker
Human Resources Directorno datageen gegevensgeen gegevens
Nikki Lumley
Company Secretary3.7yrsgeen gegevensgeen gegevens

2.3yrs

Gemiddelde duur

67yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van DCP wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Rui Morais
CEO & Executive Director12.3yrsR16.70m0.99%
ZAR 321.4m
J. Pope
CFO & Executive Director1.3yrsR5.19mgeen gegevens
Ivan Saltzman
Executive Director19.5yrsR18.45mgeen gegevens
Saul Saltzman
Executive Director2.3yrsR7.56m0.79%
ZAR 255.0m
Stanley Richard Goetsch
Executive Director2.3yrsR7.58m4.65%
ZAR 1.5b
Laurence Nestadt
Independent Non-Executive Chairman8.1yrsR3.34m0.058%
ZAR 18.9m
Johannes Mthimunye
Independent Non-Executive Director8.1yrsR967.00k0.0095%
ZAR 3.1m
Anuschka Coovadia
Independent Non-Executive Director8.1yrsR691.00k0.019%
ZAR 6.1m
Alupheli Sithebe
Independent Non-Executive Director3.8yrsR750.00kgeen gegevens
Katlego K. Kobue
Non-Independent Non Executive Director3yrsR560.00kgeen gegevens
Happy Masondo
Independent Non-Executive Director2.3yrsR788.00kgeen gegevens

3.8yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van DCP wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).